We are live on ! Find out more
Balyasny Asset Management

Balyasny Asset Management Portfolio holdings

AUM $80.2B
1-Year Est. Return 51.53%
This Fund
S&P 500
This Quarter Est. Return
+19.41%
1 Year Est. Return
+51.53%
3 Year Est. Return
+149.76%
5 Year Est. Return
+199.37%
10 Year Est. Return
+875.18%
AUM
$80.2B
AUM Growth
+$3.12B
Cap. Flow
-$3.01B
Cap. Flow %
-3.76%
Top 10 Hldgs %
13.57%
Holding
3,665
New
834
Increased
989
Reduced
995
Closed
734

Sector Composition

Rank Sector Weight
1 Miscellaneous 36.95%
2 Technology 12.69%
3 Industrials 9.95%
4 Consumer Discretionary 8.03%
5 Healthcare 7.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BG icon
501
Bunge Global
BG
$20.9B
$31.5M 0.04%
294,950
-101,274
-26% -$12.4M
CNR
502
Core Natural Resources Inc
CNR
$4.42B
$31.5M 0.04%
393,337
-17,481
-4% -$1.55M
FOXA icon
503
CALL
Fox Class A
FOXA
$26.6B
$31.3M 0.04%
+600,000
New +$37.1M
RYN icon
504
Rayonier
RYN
$5.62B
$31.2M 0.04%
1,467,064
-697,826
-32% -$14.6M
NOVT icon
505
Novanta
NOVT
$5.44B
$31.1M 0.04%
191,700
+157,453
+460% +$22.8M
ABNB icon
506
PUT
Airbnb
ABNB
$92.8B
$31M 0.04%
216,600
-66,500
-23% -$9.07M
LRCX icon
507
PUT
Lam Research
LRCX
$394B
$31M 0.04%
71,500
-27,300
-28% -$8.29M
EBAY icon
508
eBay
EBAY
$48B
$30.9M 0.04%
276,816
-349,466
-56% -$37.3M
COST icon
509
CALL
Costco
COST
$409B
$30.9M 0.04%
33,000
+24,800
+302% +$24.7M
MAIR
510
Madison Air Solutions
MAIR
$12.6B
$30.8M 0.04%
+790,973
New +$30.8M
LNTH icon
511
Lantheus
LNTH
$6.51B
$30.8M 0.04%
277,821
-261,561
-48% -$24.4M
ELVN icon
512
Enliven Therapeutics
ELVN
$3.28B
$30.8M 0.04%
607,189
+297,164
+96% +$12.6M
V icon
513
CALL
Visa
V
$690B
$30.8M 0.04%
89,800
+68,600
+324% +$22M
KMI icon
514
Kinder Morgan
KMI
$68.5B
$30.6M 0.04%
957,378
-986,912
-51% -$31.8M
EROC
515
ERock Inc
EROC
$607M
$30.4M 0.04%
+2,099,619
New +$33.4M
TPR icon
516
Tapestry
TPR
$22.7B
$30.4M 0.04%
207,777
-78,174
-27% -$11.2M
ASML icon
517
CALL
ASML
ASML
$670B
$30.2M 0.04%
15,200
+5,300
+54% +$8.44M
VRT icon
518
PUT
Vertiv
VRT
$97.5B
$30.2M 0.04%
90,100
+34,000
+61% +$10.8M
CLF icon
519
Cleveland-Cliffs
CLF
$6.95B
$30.1M 0.04%
3,208,119
+474,720
+17% +$5.22M
AUB icon
520
Atlantic Union Bankshares
AUB
$5.54B
$30.1M 0.04%
711,227
-219,499
-24% -$8.38M
STT icon
521
State Street
STT
$49.8B
$30.1M 0.04%
177,284
+173,119
+4,157% +$26.7M
EHC icon
522
Encompass Health
EHC
$12.2B
$30M 0.04%
296,939
+243,080
+451% +$25.2M
IWM icon
523
iShares Russell 2000 ETF
IWM
$77.3B
$29.9M 0.04%
+99,639
New +$28M
CBIO
524
Crescent Biopharma
CBIO
$520M
$29.9M 0.04%
1,662,917
+152,884
+10% +$2.98M
APD icon
525
Air Products & Chemicals
APD
$62.7B
$29.9M 0.04%
102,043
-623,041
-86% -$181M

Similar funds

Balyasny Asset Management's Q2 2026 Portfolio in Review

As of Q2 2026, Balyasny Asset Management held 3,665 positions worth $80.2B, up 4% from $77.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Balyasny Asset Management withdrew a net $3.01B in Q2 2026, closing 734 positions and reducing 995 holdings. Its most notable exit was Hologic, an estimated $357M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 37% of assets, down from 39% a quarter earlier, followed by Technology and Industrials.

Against the trend, Balyasny Asset Management opened a new position in SpaceX worth $581M.

  • Balyasny Asset Management's largest Q2 2026 buy was SpaceX: 3,397,642 shares worth $581M.
  • Balyasny Asset Management added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $538M increase.
  • Balyasny Asset Management's biggest Q2 2026 reduction was Meta Platforms (Facebook), cutting an estimated $326M.
  • Balyasny Asset Management fully exited Hologic in Q2 2026, selling an estimated $357M.
  • Balyasny Asset Management's ten largest holdings make up 14% of its $80.2B portfolio in Q2 2026.
  • Balyasny Asset Management opened 834 new positions and closed 734 in Q2 2026.
  • Balyasny Asset Management's portfolio value rose 4% quarter-over-quarter to $80.2B.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.